Interventional Glaucoma

The intraocular pressure-lowering drugs netarsudil ophthalmic solution 0.02% and latanoprost 0.005% administered separately and then compared with the fixed-combination formulation are similar regarding their effect on the corneal endothelium. 

It is imperative for physicians to ensure that patients are receiving the correct medications that they prescribe, and not a generic brand that may not meet the objectives. 

Education of in-hospital care givers about anti-glaucoma medications required by inpatients significantly increased the adherence rate to the medication regimens. 

Look beyond intraocular pressure for diagnosis and treatment.

OCT-A detected microcirculatory disturbances during acute post-aural migraine attacks may be an important tool in elucidating the pathophysiological relationship between migraine, aura, and ischemia.

Employees of medical marijuana dispensaries advocate drug’s benefits, contradicting the position of the American Glaucoma Society.

Visual cortical prosthesis intended to create artificial form of useful vision for blind individuals

Better visual outcomes goal for patients who also have had glaucoma procedure